101 related articles for article (PubMed ID: 19101402)
1. Introduction: Advances in treatment of metastatic colorectal cancer.
Folprecht G
Cancer Treat Rev; 2008; 34 Suppl 2():S1-2. PubMed ID: 19101402
[No Abstract] [Full Text] [Related]
2. [Systemic treatment of metastatic colorectal cancer].
Montemurro M; Achtari L; Röth A; Halkic N; Luthi F; Ozsahin M; Denys A; Bauer J; Demartines N; Leyvraz S
Rev Med Suisse; 2008 May; 4(158):1254-7. PubMed ID: 18616207
[TBL] [Abstract][Full Text] [Related]
3. [Tailored treatment to patients with metastatic colorectal cancer].
Pfeiffer P; Qvortrup C; Hansen TP
Ugeskr Laeger; 2009 Mar; 171(13):1098. PubMed ID: 19321093
[No Abstract] [Full Text] [Related]
4. [The SOR program of guidelines for clinical practice. Palliative chemotherapy as first line treatment of metastatic colorectal cancer, 2003 update].
Gastroenterol Clin Biol; 2004 Jun; 28(6-7 Pt 2):E1-71. PubMed ID: 15286580
[No Abstract] [Full Text] [Related]
5. Individualizing therapy for metastatic colorectal cancer.
Turja J; Grothey A
Oncology (Williston Park); 2008 Nov; 22(13):1479-81. PubMed ID: 19227569
[No Abstract] [Full Text] [Related]
6. [Biomarker for chemotherapy in patients with colorectal cancer].
Matsusaka S
Gan To Kagaku Ryoho; 2009 Jan; 36(1):11-4. PubMed ID: 19151559
[TBL] [Abstract][Full Text] [Related]
7. FDA approves regorafenib (Stivarga) for metastatic colorectal cancer.
Oncology (Williston Park); 2012 Oct; 26(10):896. PubMed ID: 23175993
[No Abstract] [Full Text] [Related]
8. [Second-line chemotherapy for colorectal cancer].
Komatsu Y; Sogabe S; Kawamoto Y; Iwanaga I; Uehata Y; Yuki S; Asaka M
Gan To Kagaku Ryoho; 2009 May; 36(5):721-5. PubMed ID: 19461170
[TBL] [Abstract][Full Text] [Related]
9. Therapy for colorectal cancer.
Etzioni S; Rosenfeld K
N Engl J Med; 2005 Apr; 352(17):1820-2; author reply 1820-2. PubMed ID: 15864824
[No Abstract] [Full Text] [Related]
10. Developing novel and highly effective new therapeutic strategies for treatment of colorectal cancer: where do we go from here?
Houghton JA
Curr Opin Investig Drugs; 2001 May; 2(5):674-6. PubMed ID: 11569946
[No Abstract] [Full Text] [Related]
11. Molecular markers of chemotherapy in advanced colorectal cancer: back to square one.
Sobrero A
Eur J Cancer; 2009 Jul; 45(11):1902-3. PubMed ID: 19502051
[No Abstract] [Full Text] [Related]
12. Systemic chemotherapy should be the primary treatment of synchronous colorectal metastases in the asymptomatic patient [corrected].
Petrelli NJ
Ann Surg Oncol; 2006 Feb; 13(2):137-9. PubMed ID: 16418888
[No Abstract] [Full Text] [Related]
13. Managing toxicities associated with colorectal cancer chemotherapy and targeted therapy: a new guide for nurses.
Grenon NN; Chan J
Clin J Oncol Nurs; 2009 Jun; 13(3):285-96. PubMed ID: 19502186
[TBL] [Abstract][Full Text] [Related]
14. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
Wadhawan A; Stephens R; Adams R
Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
[TBL] [Abstract][Full Text] [Related]
15. Regorafenib (Stivarga) for metastatic colorectal cancer and GIST.
Med Lett Drugs Ther; 2013 Apr; 55(1415):e36. PubMed ID: 23836345
[No Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy for metastatic colorectal cancer to the liver: from chemotherapy to targeting therapy.
Teng LS; Zheng Y; Zhang J
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):569-70. PubMed ID: 19073400
[No Abstract] [Full Text] [Related]
17. [Pharmacogenetics and tumor sensitivity of antineoplastic agents. Application to colorectal cancer].
Milano G
Rev Prat; 2008 May; 58(10):1056-9. PubMed ID: 18652401
[TBL] [Abstract][Full Text] [Related]
18. Impact of standardized Rhus verniciflua stokes extract as complementary therapy on metastatic colorectal cancer: a Korean single-center experience.
Lee SH; Choi WC; Yoon SW
Integr Cancer Ther; 2009 Jun; 8(2):148-52. PubMed ID: 19679623
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer chemotherapy.
Woodcock TM
J Ky Med Assoc; 2009 Mar; 107(3):93-4. PubMed ID: 19361080
[No Abstract] [Full Text] [Related]
20. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
